blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4169903

EP4169903 - CO-CRYSTALS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, LYSINE AND GABAPENTIN, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.03.2024
Database last updated on 14.09.2024
FormerThe application has been published
Status updated on  24.03.2023
Most recent event   Tooltip08.03.2024Application deemed to be withdrawnpublished on 10.04.2024  [2024/15]
Applicant(s)For all designated states
Dompe' Farmaceutici S.P.A.
Via Santa Lucia 6
20122 Milan / IT
[2023/17]
Inventor(s)01 / ARAMINI, Andrea
67100 L'Aquila / IT
02 / BIANCHINI, Gianluca
67100 L'Aquila / IT
03 / LILLINI, Samuele
80131 Napoli / IT
04 / TOMASSETTI, Mara
80131 Napoli / IT
05 / BRANDOLINI, Laura
67100 L'Aquila / IT
 [2023/17]
Representative(s)Mauri, Elisabetta Maria Ester
Dompé Farmaceutici S.p.A.
Via Santa Lucia, 6
20122 Milano / IT
[2023/17]
Application number, filing date21204515.725.10.2021
[2023/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4169903
Date:26.04.2023
Language:EN
[2023/17]
Search report(s)(Supplementary) European search report - dispatched on:EP12.04.2022
ClassificationIPC:C07C229/26, C07C57/30, C07C229/28, A61P29/00
[2023/17]
CPC:
A61P29/00 (EP,IL); C07C229/26 (EP,IL); C07C229/28 (EP,IL);
C07C57/30 (EP,IL); C07C57/58 (EP,IL); C07C59/64 (EP,IL);
C07C59/68 (EP,IL); C07B2200/13 (EP,IL); C07C2601/14 (EP,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/17]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:CO-KRISTALLE VON NICHTSTEROIDALEN ENTZÜNDUNGSHEMMENDEN ARZNEIMITTELN, LYSIN UND GABAPENTIN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND DEREN MEDIZINISCHE VERWENDUNG[2023/17]
English:CO-CRYSTALS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, LYSINE AND GABAPENTIN, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE[2023/17]
French:CO-CRISTAUX DE MÉDICAMENTS ANTI-INFLAMMATOIRES NON STÉROÏDIENS, LYSINE ET GABAPENTINE, COMPOSITIONS PHARMACEUTIQUES ET LEUR UTILISATION MÉDICALE[2023/17]
Examination procedure27.10.2023Application deemed to be withdrawn, date of legal effect  [2024/15]
04.12.2023Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2024/15]
Fees paidRenewal fee
27.10.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP2177215  (ESTEVE LABOR DR [ES]);
 [E]WO2021214158  (DOMPE FARM SPA [IT]);
by applicantWO2021EP60421
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.